Aspiring to Cure Cancer
double helix
Millennium: The Takeda Oncology Company combines the innovative science of a leading American biopharmaceutical company with the global assets – both intellectual and fiscal – of Japan's largest pharmaceutical company. We are focused exclusively in oncology to improve the treatment of cancer around the world.
divider
our people
We respect talent and care deeply about people. We want to make a difference we can be proud of in terms of our skill, our integrity, and our innovation.
 
our history
With more than 15 years of rapid evolution and significant success, we have good momentum as we aim toward global oncology leadership.
divider
our culture
A significant part of our success has been the culture of our company. It allows each of us to make a difference and have a voice. It's casual, entrepreneurial, and makes fun at work a probability instead of just a possibility.
divider
our policies & practices
We strive to earn the trust of our stakeholders every day. We hold ourselves accountable to act with integrity, and to be forthright and caring.

Learn how and why we do what we do.
Dr. Deborah Dunsire named to PharmaVOICE Top 100
Pharmaceutical Executive 2009 April Cover Story
“Any success I have achieved during my career has been a direct result of being open to and aware of other options that may present themselves when least expected.”

Jing Marantz selected to Pharmaceutical Executive’s list of “Emerging Pharma Leaders 2010
Pharmaceutical Executive 2009 April Cover Story
"We can no longer afford to rely solely on the ingenuity of our scientists. We must proactively monitor and acquire external assets to enhance our pipelines."
 
divider